The U.S. Food and Drug Administration today approved the first generic version of Xeloda (capecitabine), an oral chemotherapy pill used to treat cancer of the colon or rectum (colorectal cancer) that ...

Credit: FDA. Project Renewal is an Oncology Center of Excellence initiative that aims to update the labeling information for certain older oncology drugs. The Food and Drug Administration (FDA) has ...

In late April, the Mark Cuban Cost Plus Drug Company added another oncology drug to its formulary: capecitabine. This addition brings the total number of generic cancer drugs sold through Cuban's ...

Camber is offering capecitabine tablets, which is a generic of Xeloda. Capecitabine is a nucleoside metabolic inhibitor indicated for the treatment of several cancers, including: colorectal cancer, ...

LEHI, Utah, July 17, 2025 /PRNewswire/ -- CivicaScript®, LLC, a nonprofit company dedicated to bringing low-cost generic medicines to U.S. patients, today announced the availability of its generic ...

A new program allows cancer patients in Ohio to pass along their unused and unneeded oral cancer drugs to fellow patients with cancer who cannot afford the pricey pills — even if the pills are not in ...

ZURICH, Feb 24 (Reuters) - Swiss drugmaker Roche Holding AG's blockbuster cancer drug Xeloda received a European Union recommendation for a treatment of early colon cancer. Sign up here. The Committee ...

PORT WASHINGTON, N.Y., March 28, 2017 (GLOBE NEWSWIRE) -- ACETO Corporation (NASDAQ:ACET), an international company engaged in the development, marketing, sale and distribution of Human Health ...

JoEllen Zembruski-Ruple, while in the care of New York City’s renowned Memorial Sloan Kettering Cancer Center, swallowed the first three chemotherapy pills to treat her squamous cell carcinoma on Jan.

BOSTON (Reuters) - Older breast cancer patients who got Roche AG's drug Xeloda all by itself were almost twice as likely to relapse and die than women who got standard chemotherapy, U.S. researchers ...